Stuart Leigh Goldberg MD

John Theurer Cancer Center at Hackensack University Medical Center

Summary

Dr. Stuart Goldberg, based in Hackensack, NJ, is a specialist in oncology with extensive experience in hematologic malignancies, chronic myeloid leukemia, myelodysplasia, myelofibrosis, and bone marrow transplantation. He completed his medical education and training at Pennsylvania State University College of Medicine and George Washington University, followed by a fellowship at the Mayo Clinic. Dr. Goldberg previously served as Chief of the Division of Leukemia at John Theurer Cancer Center and a partner at Regional Cancer Care Associates. He also served as Chief of their Division of Outcomes Research. Dr Goldberg co- founded COTA, an oncology centered data and analytics company and served as its first Chief Medical Officer. His research has been published in several notable journals, and he has been involved in numerous clinical trials and studies related to leukemia, myelodysplastic syndromes, and other conditions. Since relocating to Miami Florida he has been involved in patient advocacy and is currently on the development and financial boards of the MDS Foundation. He works as a consultant for Outcomes Matter Innovation, a company specializing in developing value based medical solutions.

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1991 - 1992
George Washington UniversityFellowship, Hematology and Medical Oncology, 1989 - 1991
George Washington UniversityResidency, Internal Medicine, 1986 - 1989
Pennsylvania State University College of MedicineClass of 1986

David King Clinical Scientist Award Association of Community Cancer Centers, 2016
Inside Jersey Top Doctors for Cancer Castle Connolly, 2012-2015
Inside Jersey Magazine Top Doctors Castle Connolly, 2012-2015

PubMed

Journal Articles

Phase 2b Study of Two Dosing Regimens of Quizartinib Monotherapy in FLT3-ITD Mutated, Relapsed or Refractory AML
Alexander E Perl, Mark J Levis, Stuart L Goldberg, Martin S Tallman, Hagop M Kantarjian, Gary J Schiller, Blood

Abstracts/Posters

Sustained Hematopoietic Recovery after Salvage Autologous Stem Cell Transplants after Long Term Storage of Cryopreserved Hematopoietic Progenitor Stem Cells (HPSC)
Stuart L. Goldberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Evomela¬ Significantly Increases the Risk of Engraftment Syndrome in Patients with Multiple Myeloma Treated with Autologous Stem Cell Transplantation
Stuart L. Goldberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Cytogenetic and Molecular Response with First- and Second-Generation Tyrosine Kinase Inhibitor (TKI) Therapy in Simplicity: An Observational Study of Patients with Chr...
Stuart L. Goldberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Cardiovascular (CV)-Related Hospitalizations and Associated Costs Among US Patients in Simplicity: An Observational Study of Patients with Chronic-Phase Chronic Myeloi...
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Dosing Patterns of Dasatinib Use in Simplicity, an Observational Study in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients (pts) in Routine Clinical Practice
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

New Model Can Help Clinicians to Predict 40-Day Mortality Risk in Hospitalized COVID-19 PatientsAugust 2nd, 2021
On the Front Lines During the First Wave of COVID-19 Pandemic: Hackensack Meridian Health PublishingJune 5th, 2020
Hope Dims for Hydroxychloroquine Even as Medical Study Detailing the Drug’s Failure Is RetractedJune 5th, 2020